InvestorsObserver gives Abbott Laboratories (ABT) a weak valuation score of 16 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. ABT currently holds a better value than 16% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.
ABT gets a 16 Valuation Rank today. Find out what this means to you and get the rest of the rankings on ABT!